We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




AI-Enabled Plaque Assessments Help Cardiologists Identify High-Risk CAD Patients

By MedImaging International staff writers
Posted on 12 Nov 2024
Print article
Image: Cleerly offers an AI-enabled CCTA solution for personalized, precise and measurable assessment of plaque, stenosis and ischemia (Photo courtesy of Cleerly)
Image: Cleerly offers an AI-enabled CCTA solution for personalized, precise and measurable assessment of plaque, stenosis and ischemia (Photo courtesy of Cleerly)

Groundbreaking research has shown that a non-invasive, artificial intelligence (AI)-based analysis of cardiac computed tomography (CT) can predict severe heart-related events in patients exhibiting symptoms of coronary artery disease (CAD). The late-breaking results from the CONFIRM2 global multicenter study highlighted the key atherosclerotic features most strongly linked to major adverse cardiovascular events (MACE) and revealed that these features are more reliable than traditional clinical risk scores.

In this study, which involved 3,551 symptomatic patients from 18 sites across 13 countries, researchers at Leiden University Medical Center (Leiden, Netherlands) used cutting-edge AI technology to analyze coronary computed tomography angiography (CCTA) data. The analysis revealed that two specific factors were the strongest indicators of MACE: 1) % Diameter Stenosis and 2) Non-Calcified Plaque Volume. Additionally, the CONFIRM2 study demonstrated that coronary artery calcified plaque volume did not independently predict negative outcomes for patients. These findings suggest that AI-driven evaluations could play a significant role in shaping treatment decisions, improving patient outcomes, and reducing the incidence of cardiovascular events in individuals with CAD.

"The integration of AI in assessing coronary artery disease represents a transformative leap in our ability to predict and manage coronary heart disease-related events,” said Dr. James K. Min, Founder and CEO of Cleerly. “AI-QCT analysis of cardiac CT provides diameter stenosis percentages and an accurate view of non-calcified plaque volume based on millions of images. This research not only highlights the potential of AI to improve diagnostic accuracy but also the importance of early intervention in reducing the risk of serious cardiovascular events."

Ultrasound Table
Women’s Ultrasound EA Table
New
Ultrasound-Guided Biopsy & Visualization Tools
Endoscopic Ultrasound (EUS) Guided Devices
Portable Color Doppler Ultrasound System
S5000
Portable X-ray Unit
AJEX140H

Print article

Channels

MRI

view channel
Image: An AI tool has shown tremendous promise for predicting relapse of pediatric brain cancer (Photo courtesy of 123RF)

AI Tool Predicts Relapse of Pediatric Brain Cancer from Brain MRI Scans

Many pediatric gliomas are treatable with surgery alone, but relapses can be catastrophic. Predicting which patients are at risk for recurrence remains challenging, leading to frequent follow-ups with... Read more

Nuclear Medicine

view channel
Image: In vivo imaging of U-87 MG xenograft model with varying mass doses of 89Zr-labeled KLG-3 or isotype control (Photo courtesy of L Gajecki et al.; doi.org/10.2967/jnumed.124.268762)

Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors

Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.